1Tsui WM,Colombari R,Portmann BC,et al.Hepatic angiomyolipoma:a clinicopathologic study of 30 cases and delineation of unusual morphologic variants.Am J Surg Pathol,1999,23:34-48.
2Yu J,Astrinidis A,Henske EP.Chromosome 16 loss of heterozygosity in tuberous sclerosis and sporadic lymphangiomyomatosis.Am J Respir Crit Care Med,2001,164:1537-1540.
3Makhlouf HR,Remotti HE,Ishak KG.Expression of KIT (CD117) in angiomyolipoma.Am J Surg Pathol,2002,26:493-497.
4Clarkson KS,Sturdgess IC,Molyneux AJ.The usefulness of tyrosinase in the immunohistochemical assessment of melanocytic lesions:a comparison of the novel T311 antibody (anti-tyrosinase) with S-100,HMB45,and A103 (anti-melan-A).J Clin Pathol,2001,54:196-200.
6Nelson CP,Sanda MG.Contemporary diagnosis and management of renal angiomyolipoma.J Urol,2002,168:1315-1325.
7Shiga Y,Tsutsumi M,Suzuki K,et al.Angiomyolipoma with regional lymph node involvement:a case report and literature review.Hinyokika Kiyo,2003,49:81-86.
8Csanaky G,Szereday Z,Magyarlaki T,et al.Renal angiomyolipoma:report of three cases with regional lymph node involvement and/or with renal cell carcinoma.Tumori,1995,81:469-474.
